UPDATE: AbbVie (ABBV) to Advance ABT-494, Will Not Exercise Rights to Galapagos' (GLPG) Filgotinib
Tweet Send to a Friend
(Updated - September 25, 2015 7:25 AM EDT)
(Update included ticker for GLPG)AbbVie (NYSE: ABBV), a global biopharmaceutical company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(Update included ticker for GLPG)AbbVie (NYSE: ABBV), a global biopharmaceutical company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
